Form 4: Trupanion Executive Reports Routine Stock Vesting and Tax Withholding
Insider Transaction Report
Steve Weinrauch, EVP of North America and Vet Strategy at Trupanion, Inc., reported the vesting and conversion of restricted stock units into common stock, alongside shares withheld for tax obligations, as part of routine compensation.
Summary
- Steve Weinrauch, EVP, North America & Vet Strategy at Trupanion, Inc. (TRUP), reported multiple transactions on May 25, 2025, related to the vesting of Restricted Stock Units (RSUs).
- A total of 925 Restricted Stock Units (40, 354, and 531 RSUs) vested and converted into an equal number of common shares.
- Concurrently, 224 shares of common stock (9, 86, and 129 shares) were withheld by Trupanion at a price of $47.78 per share to cover income tax withholding obligations associated with the RSU vesting.
- These transactions are not sales by the reporting person but rather standard procedures for RSU vesting and tax satisfaction.
- Following these transactions, Mr. Weinrauch's direct beneficial ownership of Trupanion common stock stands at 59,457 shares.
- He also holds remaining derivative securities in the form of RSUs: 284 RSUs vesting until February 25, 2027; 3,181 RSUs vesting until August 25, 2027; and 1,592 RSUs vesting until February 25, 2026.
Sentiment
Score: 5
Explanation: The document is a routine compliance filing (Form 4) reporting standard executive compensation transactions (RSU vesting and tax withholding). It does not contain information that would significantly alter the company's financial outlook or operational status, thus indicating a neutral sentiment.
Positives
- The vesting of Restricted Stock Units (RSUs) represents a realization of previously granted equity compensation for the executive.
- The conversion of RSUs into common stock increases the executive's direct ownership in the company, aligning interests with shareholders.
Negatives
- A portion of the vested shares was withheld for tax purposes, reducing the net number of shares received by the executive.
Future Outlook
The document indicates ongoing quarterly vesting schedules for the remaining Restricted Stock Units held by the reporting person, subject to continued service.
Industry Context
This Form 4 filing reflects a routine executive compensation event within the pet insurance industry, where equity grants like Restricted Stock Units are common tools for aligning executive incentives with company performance and long-term shareholder value.
Comparison to Industry Standards
- The use of Restricted Stock Units (RSUs) as a component of executive compensation is a standard practice across various industries, including the pet insurance sector, aligning executive interests with long-term company performance.
- The one-for-one conversion of RSUs to common stock and the withholding of shares for tax obligations are typical mechanisms for managing equity compensation and tax compliance, consistent with practices at comparable publicly traded companies like Zoetis Inc. (ZTS) or IDEXX Laboratories, Inc. (IDXX) which also utilize equity-based incentives for their executives.
Related Party Transactions
- The reported transactions involve the vesting of Restricted Stock Units granted by Trupanion, Inc. to its EVP, Steve Weinrauch, which is a standard compensation arrangement between the company and its executive.
Stakeholder Impact
- Shareholders: The increase in the executive's direct share ownership aligns management's interests with those of shareholders, potentially fostering long-term value creation.
- Employees: This filing provides transparency regarding executive compensation practices, which can influence employee perception of fairness and compensation structures within the company.
Next Steps
- Continued quarterly vesting of the remaining Restricted Stock Units (RSUs) held by the reporting person, subject to continued service through each vest date.
Key Dates
| Date | Description |
|---|---|
| 02/28/2022 | Date when 8,490 Restricted Stock Units (RSUs) were granted to the reporting person. |
| 02/25/2023 | Date when 1/4th of the 8,490 RSUs granted on 02/28/2022 vested and converted into common stock. |
| 02/27/2023 | Date when 649 Restricted Stock Units (RSUs) were granted to the reporting person. |
| 08/14/2023 | Date when 5,655 Restricted Stock Units (RSUs) were granted to the reporting person. |
| 02/25/2024 | Date when 1/4th of the 649 RSUs granted on 02/27/2023 vested and converted into common stock. |
| 08/25/2024 | Date when 1/4th of the 5,655 RSUs granted on 08/14/2023 vested and converted into common stock. |
| 05/25/2025 | Date of the reported transactions, including RSU vesting and conversion to common stock, and shares withheld for tax obligations. |
| 05/28/2025 | Date the Form 4 filing was signed. |
| 02/25/2026 | Expiration date for the remaining 1,592 RSUs from the 02/28/2022 grant, subject to continued quarterly vesting. |
| 02/25/2027 | Expiration date for the remaining 284 RSUs from the 02/27/2023 grant, subject to continued quarterly vesting. |
| 08/25/2027 | Expiration date for the remaining 3,181 RSUs from the 08/14/2023 grant, subject to continued quarterly vesting. |
Keywords
Trupanion, TRUP, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Equity Compensation, Stock Ownership, Executive Compensation, Steve Weinrauch
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.